KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome.

Eur Heart J · 2024 · PMC11439107 · PMID 39115049

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The QTi of the LQT1 rabbits 2 weeks post-AAV9-KCNQ1-SupRep treatment (113 ± 3%, P = .09) showed a trend towards a shorter QTi than the QTi of UT-LQT1 (122 ± 3%) rabbits.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.